Carmoterol-impurities | Pharmaffiliates

carmoterol

Carmoterol was being developed by the licensee company Chiesi in clinical trials as a once-daily therapy for chronic obstructive pulmonary disease. It is a non-catechol. Reference standards of Carmoterol API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Carmoterol-d3 Hydrochloride
    [catalogue_number] => PA STI 018060
    [category_ids] => ,80,69,71,78,70,82,98,
    [chemical_name] => 
    [weight] => 407.91
    [form] => C21H22D3ClN2O4
    [cas] => 1276319-69-7
    [pslug] => 1276319-69-7-carmoterol-d3-hydrochloride-pasti018060
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA STI 018060

Carmoterol-d3 Hydrochloride


  • Catalogue No.:PA STI 018060

  • CAS :

    1276319-69-7

  • Molecular Formula : C21H22D3ClN2O4

  • Molecular Weight : 407.91